People around the world, worried for their health and their economic security, anxiously await an effective and widely available vaccine for COVID-19. But vaccines often take years or decades to develop, test, and clear for broad distribution. Chicago Booth’s Joshua P. Fairbank explains how US regulators are working with private companies to speed up the creation and approval of treatments and vaccines in order to shorten the crisis and speed recovery.

More from Chicago Booth Review

More from Chicago Booth

Your Privacy
We want to demonstrate our commitment to your privacy. Please review Chicago Booth's privacy notice, which provides information explaining how and why we collect particular information when you visit our website.